Mediwhale
  • About
    • Founder Story
    • Dr. Noon
    • Leadership
    • Journey
  • Products
    • Dr. Noon CVD
    • Dr. Noon CKD
    • Dr. Noon Fundus
    • Dr. Noon Age
  • Resources
    • Publications
    • English News
    • Korean News
  • Careers
  • Contact
  • ko_KRKO
Select Page

Big data and artificial intelligence in ophthalmology

Jul 18, 2023 | Frontiers in Medicine

Frontiers in Medicine, February 2023 Editorial on the Research Topic Big Data and Artificial Intelligence (AI) are rapidly transforming modern healthcare. The combination of these technologies allows for the collection, analysis, and utilization of large amounts of...

Artificial Intelligence in Predicting Systemic Disease from Ocular Imaging

Feb 18, 2023 | Digital Eye Care and Teleophthalmology

Digital Eye Care and Teleophthalmology | June 20, 2023 Abstract Artificial Intelligence (AI) has diverse applications in modern health care. Deep learning (DL) systems in ophthalmology have been used to predict and classify several ocular pathologies. In recent years,...

Non-invasive chronic kidney disease risk stratification tool derived from retina-based deep learning and clinical factors

Jul 12, 2023 | Nature | npj Digital Medicine

Nature | npj Digital Medicine, June 2023 Abstract Despite the importance of preventing chronic kidney disease (CKD), predicting high-risk patients who require active intervention is challenging, especially in people with preserved kidney function. In this study, a...

Cardiovascular disease risk assessment using a deep-learning-based retinal biomarker: a comparison with existing risk scores

Jun 2, 2023 | European Heart Journal

European Heart Journal – Digital Health, April 2023 Aims This study aims to evaluate the ability of a deep-learning-based cardiovascular disease (CVD) retinal biomarker, Reti-CVD,to identify individuals with intermediate- and high-risk for CVD. Methods and...

Validation of a deep-learning-based retinal biomarker (Reti-CVD) in the prediction of cardiovascular disease: data from UK Biobank

Jan 27, 2023 | BMC Medicine

BMC Medicine, January 2023 Background Currently in the United Kingdom, cardiovascular disease (CVD) risk assessment is based on the QRISK3 score, in which 10% 10-year CVD risk indicates clinical intervention. However, this benchmark has limited efficacy in clinical...

Predictive, preventive, and personalized management of retinal fluid via computer-aided detection app for optical coherence tomography scans

Nov 21, 2022 | EPMA Journal

EPMA Journal, November 2022 Aims Computer-aided detection systems for retinal fluid could be beneficial for disease monitoring and management by chronic age-related macular degeneration (AMD) and diabetic retinopathy (DR) patients, to assist in disease prevention via...
Page 4 of 9« First«...23456...»Last »

Let’s build the future of digital healthcare together

Connect with us

ABOUT

Founder Story

Dr. Noon

Leadership

Journey

PRODUCTS

Dr. Noon CVD

Dr. Noon CKD

Dr. Noon Fundus

Dr. Noon Age

RESOURCES

Publications

English News

Korean News

CAREERS

CONTACT

NEWSLETTER

FOLLOW US

  • Follow
  • Follow
  • Follow
  • Follow

Copyright © 2023 Mediwhale Inc. All rights reserved.      Privacy Policy  |  Terms of Use